Travere Therapeutics Switzerland GmbH

Biotechnology · Rapperswil SG, St. Gallen

Travere Therapeutics Switzerland GmbH is a Swiss biotechnology company based in Rapperswil SG, Canton of St. Gallen, listed in the Swiss commercial register since 2021 (UID CHE-436.614.905). It is a subsidiary of Travere Therapeutics.

Legal nameTravere Therapeutics Switzerland GmbH
AddressZürcherstrasse 6, Rapperswil SG
UID / VATCHE-436.614.905
Legal form · StatusGmbH · Active · 2021
Parent companyTravere Therapeutics

Board members & signatories

  • Christian Ellereit — Geschäftsführer
  • Giovanni Stropoli — Vorsitzender der Geschäftsführung
  • Pieter Heerma — Geschäftsführer

Registered purpose

Die Gesellschaft bezweckt die Forschung, Entwicklung und Vermarktung im Bereich von Pharmaprodukten. Die Gesellschaft kann Immaterialgüterrechte erwerben, verwalten und übertragen, Grundstücke im In- und Ausland erwerben, verwalten und veräussern sowie sich an anderen Unternehmen im In- und Ausland beteiligen, im In- und Ausland Zweigniederlassungen errichten und Tochtergesellschaften gründen. Die…

🔒 Website🔒 Employees🔒 Revenue estimate

Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026

What Travere Therapeutics Switzerland does

OFFERING

Travere Therapeutics develops therapies for rare kidney diseases, including Focal Segmental Glomerulosclerosis (FSGS), Classical Homocystinuria (HCU), Cystinuria, and IgA Nephropathy (IgAN). Their product lines include Filspari®, Thiola®, and Thiola EC®, which are registered trademarks. The company emphasizes patient support and community engagement throughout the therapeutic development process.

Unlock the full analysis →

Similar companies

Find every biotechnology company in Switzerland

Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.

family-owned biotechnology companies with 50+ employees…Search →

Full profiles from CHF 49/month · Cancel anytime